Retatrutide 10mg
Retatrutide is a synthetic peptide that simultaneously activates the GLP‑1, GIP, and glucagon receptors, and is being investigated for its potential to support weight management and metabolic health.
Request COA opens a chat with Jenny — she'll send the most recent Certificate of Analysis (purity, sterility, identity) so you can verify before ordering.
Retatrutide belongs to a class of multi‑agonist peptide agents that target three gut hormone pathways linked to energy regulation. By engaging GLP‑1, GIP, and glucagon receptors, it influences appetite, glucose processing, and lipid metabolism, which are areas of interest for weight reduction and insulin sensitivity. The material is supplied as a sterile lyophilized powder that must be reconstituted with sterile water and kept refrigerated to preserve potency. Proper aseptic technique and handling are recommended when preparing the peptide.
Dosage Protocol: Starting Dose: 2.5mg injected subcutaneously once weekly for the first 2 or 4 weeks. Standard Dosage: 5mg weekly after the initial adjustment period. Advanced Use: Dosages may be increased incrementally up to 10mg weekly, based on individual response. Tips: Administer at the same time each week, rotate injection sites, and store the solution properly in a refrigerator.
Verbatim reference from public source. Aevum does not prescribe; outline is shown for informational and educational purposes only. Always consult a qualified practitioner.
This component is sold in 10mg vials. Add it to your stack to compute total vials needed for your run length and dosing schedule.
The information shown here is for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Aevum does not sell, source, or administer any component. Always consult a qualified practitioner before acting on any protocol.